Several randomized trials with metabolic outcomes have reported that glucagon like peptide-1 receptor agonists (GLP-1 RA) could be associated with an increased risk of pancreatitis. The present meta-analysis aimed to examine this hypothesis.

Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials / Monami, Matteo; Dicembrini, Ilaria; Nardini, Camilla; Fiordelli, Irene; Mannucci, Edoardo. - In: DIABETES RESEARCH AND CLINICAL PRACTICE. - ISSN 0168-8227. - STAMPA. - 103:(2014), pp. 269-275. [10.1016/j.diabres.2014.01.010]

Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials

DICEMBRINI, ILARIA;MANNUCCI, EDOARDO
2014

Abstract

Several randomized trials with metabolic outcomes have reported that glucagon like peptide-1 receptor agonists (GLP-1 RA) could be associated with an increased risk of pancreatitis. The present meta-analysis aimed to examine this hypothesis.
2014
103
269
275
Monami, Matteo; Dicembrini, Ilaria; Nardini, Camilla; Fiordelli, Irene; Mannucci, Edoardo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1010805
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 58
social impact